In vivo formation of N-acyl-fumonisin B1

Mycotoxin Research

Volumn 31, Issue 1, 2015, Pages 33-40

  Harrer, Henning ^a   Humpf, Hans Ulrich ^a   Voss, Kenneth A ^b,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c RUSSELL RESEARCH CENTER   (United States)

Author keywords

Biodistribution; Fumonisin; Metabolism; Mycotoxin; N acyl fumonisins

Indexed keywords

MYCOTOXIN; N ACYL FUMONISIN B 1; UNCLASSIFIED DRUG; FUMONISIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IN VIVO STUDY; KIDNEY; LIVER; MALE; MASS SPECTROMETRY; METABOLITE; NONHUMAN; RAT; TARGET ORGAN; TOXICITY ASSAY; ANIMAL; BIOTRANSFORMATION; CHEMISTRY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BIOTRANSFORMATION; FUMONISINS; KIDNEY; LIVER; MALE; MASS SPECTROMETRY; RATS, SPRAGUE-DAWLEY;

EID: 84922092479     PISSN: 01787888     EISSN: 18671632     Source Type: Journal    
DOI: 10.1007/s12550-014-0211-5     Document Type: Article

References (30)

1. Bulder AS, Arcella D, Bolger M, Carrington C, Kpodo K, Resnik S, Riley RT, Wolterink G, Wu F (2012) Fumonisins (addendum), in: safety evaluation of certain food additives and contaminants. WHO Food Additives Series 65, World Health Organization. Geneva 65:325–794
2. Burns TD, Snook ME, Riley RT, Voss KA (2008) Fumonisin concentrations and in vivo toxicity of nixtamalized Fusarium verticillioides culture material: evidence for fumonisin-matrix interactions. Food Chem Toxicol 46:2841–2848
3. Collins TFX, Sprando RL, Black TN, Olejnik N, Eppley RM, Shackelford ME, Howard PC, Rorie JI, Bryant M, Ruggles DI (2006) Effects of aminopentol on in utero development in rats. Food Chem Toxicol 44:161–169
4. Dragan YP, Bidlack WR, Cohen SM, Goldsworthy TL, Hard GC, Howard PC, Riley RT, Voss KV (2001) Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B1 as an example. Toxicol Sci 61:6–17
5. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP (1988) Fumonisins—novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 54:1806–1811
6. Gelderblom WCA, Cawood ME, Snyman SD, Vleggaar R, Marasas WFO (1993) Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays. Food Chem Toxicol 31:407–414
7. Gelineau-van Waes J, Starr L, Maddox J, Aleman F, Voss KA, Wilberding J, Riley RT (2005) Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model. Birth Defects Res A Clin Mol Teratol 73:487–497
8. Gelineau-van Waes J, Voss KA, Stevens VL, Speer MC, Riley RT (2009) Maternal fumonisin exposure as a risk factor for neural tube defects. Adv Food Nutr Res 56:145–181
9. Gelineau-van Waes J, Rainey MA, Maddox JR, Voss KA, Sachs AJ, Gardner NM, Wilberding JD, Riley RT (2012) Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720. Birth Defects Res A Clin Mol Teratol 94:790–803
10. Harrer H, Laviad EL, Humpf HU, Futerman AH (2013) Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites of fumonisin mycotoxins. Mol Nutr Food Res 57:516–522
11. Harrison LR, Colvin BM, Greene JT, Newman LE, Cole JR Jr (1990) Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 2:217–221
12. Howard PC, Eppley RM, Stack ME, Warbritton A, Voss KA, Lorentzen RJ, Kovach RM, Bucci TJ (2001) Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ Health Perspect 109(Suppl 2):277–282
13. Howard PC, Couch LH, Patton RE, Eppley RM, Doerge DR, Churchwell MI, Marques MM, Okerberg CV (2002) Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F(1) mice. Toxicol Appl Pharmacol 185:153–165
14. Hübner F, Harrer H, Fraske A, Kneifel S, Humpf HU (2012) Large scale purification of B-type fumonisins using centrifugal partition chromatography (CPC). Mycotoxin Res 28:37–43
15. Humpf HU, Schmelz EM, Meredith FI, Vesper H, Vales TR, Wang E, Menaldino DS, Liotta DC, Merrill AH Jr (1998) Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor. J Biol Chem 273:19060–19064
16. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH Jr, Futerman AH (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283:5677–5684
17. Lukacs Z, Schaper S, Herderich M, Schreier P, Humpf HU (1996) Identification and determination of fumonisin FB1 and FB2 in corn and corn products by high-performance liquid chromatography-electrospray-ionization tandem mass spectrometry (HPLC-ESI-MS-MS). Chromatographia 43:124–128
18. Marasas WF, Kellerman TS, Gelderblom WC, Coetzer JA, Thiel PG, van der Lugt JJ (1988) Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 55:197–203
19. Martinez-Larranaga MR, Anadon A, Diaz MJ, Fernandez-Cruz ML, Martinez MA, Frejo MT, Martinez M, Fernandez R, Anton RM, Morales ME, Tafur M (1999) Toxicokinetics and oral bioavailability of fumonisin B1. Vet Hum Toxicol 41:357–362
20. Pewzner-Jung Y, Ben-Dor S, Futerman AH (2006) When do Lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J Biol Chem 281:25001–25005
21. Riley RT, Voss KA (2006) Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ-specific differences in toxin accumulation and sphingoid base metabolism. Toxicol Sci 92:335–345
22. Seefelder W, Humpf HU, Schwerdt G, Freudinger R, Gekle M (2003) Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. Toxicol Appl Pharmacol 192(2):146–153
23. Seiferlein M, Humpf HU, Voss KA, Sullards MC, Allegood JC, Wang E, Merrill AH Jr (2007) Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites. Mol Nutr Food Res 51:1120–1130
24. Shephard GS, Thiel PG, Sydenham EW, Alberts, Cawood ME (1994) Distribution and excretion of a single dose of the mycotoxin Fumonisin B1 in a non-human primate. Toxicon 32:735–741
25. Shephard GS, Thiel PG, Sydenham EW, Savard ME (1995) Fate of a single dose of 14C-labelled fumonisin B1 in vervet monkeys. Nat Toxins 3:145–150
26. Voss KA, Norred WP, Plattner RD, Bacon CW (1989) Hepatotoxicity and renal toxicity in rats of corn samples associated with field cases of equine leukoencephalomalacia. Food Chem Toxicol 27:89–96
27. Voss KA, Riley RT, Norred WP, Bacon CW, Meredith FI, Howard PC, Plattner RD, Collins TF, Hansen DK, Porter JK (2001) An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect 109(Suppl 2):259–266
28. 1 did not cause neural tube defects. Toxicol Sci 112:459–467
29. Voss KA, Riley RT, Jackson LS, Jablonski JE, Bianchini A, Bullerman LB, Hanna MA, Ryu D (2011) Extrusion cooking with glucose supplementation of fumonisin-contaminated corn grits protects against nephrotoxicity and disrupted sphingolipid metabolism in rats. Mol Nutr Food Res 55:S312-S320. Erratum in: (2011) Mol Nutr Food Res 55:1597
30. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr (1991) Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 266:14486–14490